Figure 10.Drug sensitivity analysis. To improve the prognosis of HCC patients, we screened candidate drugs related to the prognosis model through the cellMiner website. The candidates are Nelarabine, Fluphenazine, Dexamethasone Decadr, etc.
Figure 10 — An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis | Aging
